| 1 | ACTN4, KNG1
|
| Domain 5 of high molecular weight kininogen inhibits collagen-mediated cancer cell adhesion and invasion in association with α-actinin-4.
|
| Hatoh T, Maeda T, Takeuchi K, Ogikubo O, Uchiyama S, Otsuka T, Ohkubo I, Ogita H.
|
| Biochem Biophys Res Commun 427(3):497-502. doi: 10.1016/j.bbrc.2012.09.079. Epub 2012 Sep 20.
2012
|
| 2 | KNG1
|
| KNG1 Ile581Thr and susceptibility to venous thrombosis.
|
| Morange PE, Oudot-Mellakh T, Cohen W, Germain M, Saut N, Antoni G, Alessi MC, Bertrand M, Dupuy AM, Letenneur L, Lathrop M, Lopez LM, Lambert JC, Emmerich J, Amouyel P, Trégouët DA.
|
| Blood 117(13):3692-4. Epub 2011 Jan 26.
2011
|
| 3 | KNG1
|
| Bradykinin promotes the chemotactic invasion of primary brain tumors.
|
| Montana V, Sontheimer H.
|
| J Neurosci. 31(13):4858-67. 2011
|
| 4 | F12, HRG, KNG1
|
| Common variants of large effect in F12, KNG1, and HRG are associated with activated partial thromboplastin time.
|
| Houlihan LM, Davies G, Tenesa A, Harris SE, Luciano M, Gow AJ, McGhee KA, Liewald DC, Porteous DJ, Starr JM, Lowe GD, Visscher PM, Deary IJ.
|
| Am J Hum Genet 86(4):626-31. Epub 2010 Mar 18.PMID: 20303064 2010
|
| 5 | KNG1, PRTN3
|
| Neutrophil-derived proteinase 3 induces kallikrein-independent release of a novel vasoactive kinin.
|
| Kahn R, Hellmark T, Leeb-Lundberg LM, Akbari N, Todiras M, Olofsson T, Wieslander J, Christensson A, Westman K, Bader M, Müller-Esterl W, Karpman D.
|
| J Immunol 182(12):7906-15. doi: 10.4049/jimmunol.0803624.
2009
|
| 6 | KLKB1, KNG1
|
| Identification of lipopolysaccharide binding site on high molecular weight kininogen.
|
| Perkins R, Ngo MD, Mahdi F, Shariat-Madar Z.
|
| Biochem Biophys Res Commun 366(4):938-43. Epub 2007 Dec 18.
2008
|
| 7 | KNG1
|
| Deletion of murine kininogen gene 1 (mKng1) causes loss of plasma kininogen and delays thrombosis.
|
| Merkulov S, Zhang WM, Komar AA, Schmaier AH, Barnes E, Zhou Y, Lu X, Iwaki T, Castellino FJ, Luo G, McCrae KR.
|
| Blood. 111(3):1274-81. 2008
|
| 8 | KLKB1, KNG1
|
| Molecular modeling of the prekallikrein structure provides insights into high-molecular-weight kininogen binding and zymogen activation.
|
| Hooley E, McEwan PA, Emsley J.
|
| J Thromb Haemost 5(12):2461-6. Epub 2007 Oct 8.
2007
|
| 9 | KLKB1, KLKB1D, KNG1
|
| A new type of plasma prekallikrein deficiency associated with homozygosity for Gly104Arg and Asn124Ser in apple domain 2 of the heavy-chain region.
|
| Katsuda I, Maruyama F, Ezaki K, Sawamura T, Ichihara Y.
|
| Eur J Haematol 79(1):59-68. Erratum in: Eur J Haematol. 2007 Aug;79(2):185. 2007
|
| 10 | KNG1
|
| T-kininogen, a cystatin-like molecule, inhibits ERK-dependent lymphocyte proliferation.
|
| Acuna-Castillo C, Aravena M, Leiva-Salcedo E, Perez V, Gomez C, Sabaj V, Nishimura S, Perez C, Colombo A, Walter R, Sierra F.
|
| Mech Ageing Dev 126(12):1284-91. Epub 2005 Sep 2. 2005
|
| 11 | KNG1
|
| Domain 5 of high molecular weight kininogen is antibacterial.
|
| Nordahl EA, Rydengard V, Morgelin M, Schmidtchen A.
|
| J Biol Chem 280(41):34832-9. Epub 2005 Aug 9. 2005
|
| 12 | KNG1
|
| Mapping the interaction between high molecular mass kininogen and the urokinase plasminogen activator receptor.
|
| Mahdi F, Shariat-Madar Z, Kuo A, Carinato M, Cines DB, Schmaier AH.
|
| J Biol Chem 279(16):16621-8. Epub 2004 Feb 5. 2004
|
| 13 | KNG1, PLAUR
|
| Mapping the interaction between high molecular mass kininogen and the urokinase plasminogen activator receptor.
|
| Mahdi F, Shariat-Madar Z, Kuo A, Carinato M, Cines DB, Schmaier AH.
|
| J Biol Chem 279(16):16621-8. Epub 2004 Feb 5.
2004
|
| 14 | KNG1
|
| Effect of His-Gly-Lys motif derived from domain 5 of high molecular weight kininogen on suppression of cancer metastasis both in vitro and in vivo.
|
| Kawasaki M, Maeda T, Hanasawa K, Ohkubo I, Tani T.
|
| J Biol Chem 278(49):49301-7. Epub 2003 Sep 23. 2003
|
| 15 | KNG1
|
| Human kininogen gene is transactivated by the farnesoid X receptor.
|
| Zhao A, Lew JL, Huang L, Yu J, Zhang T, Hrywna Y, Thompson JR, de Pedro N, Blevins RA, Pelaez F, Wright SD, Cui J.
|
| J Biol Chem 278(31):28765-70. Epub 2003 May 21. 2003
|
| 16 | KNG1, KNG
|
| Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis.
|
| Colman RW, Jameson BA, Lin Y, Johnson D, Mousa SA.
|
| Blood 95(2):543-50. 2000
|
| 17 | KNG1, KRT1
|
| Mapping binding domains of kininogens on endothelial cell cytokeratin 1.
|
| Shariat-Madar Z, et al.
|
| J Biol Chem 274(11):7137-45. 1999
|
| 18 | KNG, KNG1, KRT1
|
| Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells.
|
| Hasan AAK, et al.
|
| Proc Natl Acad Sci U S A 95(7):3615-20 1998
|
| 19 | AHSG, HRG, KNG1
|
| Three members of the human cystatin gene superfamily, AHSG, HRG, and KNG, map within one megabase of genomic DNA at 3q27.
|
| Rizzu P, et al.
|
| Cytogenet Cell Genet 70 : 26-28. 1995
|
| 20 | KNG1
|
| Chromosomal mapping of human kininogen gene (KNG) to 3q26-qter.
|
| Cheung PP, et al.
|
| Cytogenet Cell Genet 59 : 24-26. 1992
|
| 21 | KNG1
|
| The human kininogen gene (KNG) mapped to chromosome 3q26-qter by analysis of somatic cell hybrids using the polymerase chain reaction.
|
| Fong D, et al.
|
| Hum Genet 87 : 189-192. 1991
|
| 22 | KNG, KNG1
|
| Molecular genetic survey of five Japanese families with high-molecular-weight kininogen deficiency.
|
| Hayashi H, et al.
|
| Blood 75 : 1296-1304. 1990
|
| 23 | KNG1
|
| Structural organization of the human kininogen gene and a model for its evolution.
|
| Kitamura N, et al.
|
| J Biol Chem 260 : 8610-8617. 1985
|
| 24 | KNG, KNG1
|
| A hitherto undescribed plasma factor acting at the contact phase of blood coagulation (Flaujeac factor) : case report and coagulation studies.
|
| Lacombe MJ, et al.
|
| Blood 46 : 761-768. 1975
|